SEC Tracker
Get the app

Keenova Therapeutics

GOLDENTREE ASSET MANAGEMENT LP acquired 463,000 ordinary shares

GOLDENTREE ASSET MANAGEMENT LP, insider filing for Keenova Therapeutics plc

Form
4
Filed
Importance
Routine
  1. Acquired 463,000 ordinary shares
  2. Owned 8,442,827 shares indirectly
  3. Reported by Steven A. Tananbaum

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Keenova Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. America Great Health AAGH
  2. Nika Pharmaceuticals NIKA
  3. Regenerex Pharma RGPX
  4. CNBX Pharmaceuticals CNBX public float $252K, Aug 31, 2025
  5. NovAccess Global XSNX public float $338K, Mar 31, 2025, over 18 months old